Skip to content
Dx

ICD-10-CM 2027

ICD-10 code for Long-term drug therapy

Choose a code from the options below based on the documentation.

From the official ICD-10-CM alphabetic index entry “Long-term (current) (prophylactic) drug therapy (use of)”. Page updated September 29, 2026.

About coding Long-term drug therapy

The official ICD-10-CM index doesn't give a single default code for long-term drug therapy; the code depends on the details below.

More specific Long-term drug therapy codes (official index)

  • 5-fluorouracil Z79.631 — Long term (current) use of antimetabolite agent
  • 6-mercaptopurine Z79.631 — Long term (current) use of antimetabolite agent
  • adalimumab Z79.620 — Long term (current) use of immunosuppressive biologic
  • agents affecting estrogen receptors and estrogen levels NEC Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • alkylating agent Z79.630 — Long term (current) use of alkylating agent
  • anastrozole (Arimidex) Z79.811 — Long term (current) use of aromatase inhibitors
  • antibiotics Z79.2 — Long term (current) use of antibiotics
  • short-term use - omit code
  • anticoagulants Z79.01 — Long term (current) use of anticoagulants
  • antidiabetic drugs, injectable, non-insulin Z79.85 — Long-term (current) use of injectable non-insulin antidiabetic drugs
  • anti-inflammatory, non-steroidal (NSAID) Z79.1 — Long term (current) use of non-steroidal anti-inflammatories (NSAID)
  • antimetabolite agent Z79.631 — Long term (current) use of antimetabolite agent
  • antiplatelet Z79.02 — Long term (current) use of antithrombotics/antiplatelets
  • antithrombotics Z79.02 — Long term (current) use of antithrombotics/antiplatelets
  • antitumor antibiotic Z79.632 — Long term (current) use of antitumor antibiotic
  • apremilast Z79.61 — Long term (current) use of immunomodulator
  • aromatase inhibitors Z79.811 — Long term (current) use of aromatase inhibitors
  • aspirin Z79.82 — Long term (current) use of aspirin
  • azathioprine Z79.624 — Long term (current) use of inhibitors of nucleotide synthesis
  • birth control pill or patch Z79.3 — Long term (current) use of hormonal contraceptives
  • bisphosphonates Z79.83 — Long term (current) use of bisphosphonates
  • bleomycin Z79.632 — Long term (current) use of antitumor antibiotic
  • calcineurin inhibitor Z79.621 — Long term (current) use of calcineurin inhibitor
  • chlorambucil Z79.630 — Long term (current) use of alkylating agent
  • cisplatin Z79.630 — Long term (current) use of alkylating agent
  • contraceptive, oral Z79.3 — Long term (current) use of hormonal contraceptives
  • cyclophosphamide Z79.630 — Long term (current) use of alkylating agent
  • cyclosporine Z79.621 — Long term (current) use of calcineurin inhibitor
  • cytarabine Z79.631 — Long term (current) use of antimetabolite agent
  • doxorubicin Z79.632 — Long term (current) use of antitumor antibiotic
  • drug, specified NEC Z79.899 — Other long term (current) drug therapy
  • estrogen receptor downregulators Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • etanercept Z79.620 — Long term (current) use of immunosuppressive biologic
  • etoposide Z79.634 — Long term (current) use of topoisomerase inhibitor
  • Evista Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • exemestane (Aromasin) Z79.811 — Long term (current) use of aromatase inhibitors
  • Fareston Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • fulvestrant (Faslodex) Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • gonadotropin-releasing hormone (GnRH) agonist Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • goserelin acetate (Zoladex) Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • hormone replacement Z79.890 — Hormone replacement therapy
  • hydroxyurea Z79.64 — Long term (current) use of myelosuppressive agent
  • immunomodulators, unspecified Z79.60 — Long term (current) use of unspecified immunomodulators and immunosuppressants
  • specified NEC Z79.69 — Long term (current) use of other immunomodulators and immunosuppressants
  • immunomodulatory imide drug Z79.61 — Long term (current) use of immunomodulator
  • immunosuppressants, unspecified Z79.60 — Long term (current) use of unspecified immunomodulators and immunosuppressants
  • specified NEC Z79.69 — Long term (current) use of other immunomodulators and immunosuppressants
  • immunosuppressive biologic Z79.620 — Long term (current) use of immunosuppressive biologic
  • infliximab Z79.620 — Long term (current) use of immunosuppressive biologic
  • inhibitors of nucleotide synthesis Z79.624 — Long term (current) use of inhibitors of nucleotide synthesis
  • insulin Z79.4 — Long term (current) use of insulin
  • irinotecan Z79.634 — Long term (current) use of topoisomerase inhibitor
  • Janus kinase inhibitor Z79.622 — Long term (current) use of Janus kinase inhibitor
  • lenalidomide Z79.61 — Long term (current) use of immunomodulator
  • letrozole (Femara) Z79.811 — Long term (current) use of aromatase inhibitors
  • leuprolide acetate (leuprorelin) (Lupron) Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • mammalian target of rapamycin (mTOR) inhibitor Z79.623 — Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
  • megestrol acetate (Megace) Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • methadone for pain management Z79.891 — Long term (current) use of opiate analgesic
  • mitomycin C Z79.632 — Long term (current) use of antitumor antibiotic
  • mitotic inhibitor Z79.633 — Long term (current) use of mitotic inhibitor
  • monoclonal antibodies Z79.620 — Long term (current) use of immunosuppressive biologic
  • mycophenolate Z79.624 — Long term (current) use of inhibitors of nucleotide synthesis
  • myelosuppressive agent Z79.64 — Long term (current) use of myelosuppressive agent
  • Nolvadex Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • non-insulin antidiabetic drug, injectable Z79.85 — Long-term (current) use of injectable non-insulin antidiabetic drugs
  • non-steroidal anti-inflammatories (NSAID) Z79.1 — Long term (current) use of non-steroidal anti-inflammatories (NSAID)
  • opiate analgesic Z79.891 — Long term (current) use of opiate analgesic
  • oral
  • antidiabetic Z79.84 — Long term (current) use of oral hypoglycemic drugs
  • contraceptive Z79.3 — Long term (current) use of hormonal contraceptives
  • hypoglycemic Z79.84 — Long term (current) use of oral hypoglycemic drugs
  • paclitaxel Z79.633 — Long term (current) use of mitotic inhibitor
  • plant alkaloids Z79.633 — Long term (current) use of mitotic inhibitor
  • pomalidomide Z79.61 — Long term (current) use of immunomodulator
  • purine synthesis (IMDH) inhibitors Z79.624 — Long term (current) use of inhibitors of nucleotide synthesis
  • raloxifene (Evista) Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • selective estrogen receptor modulators (SERMs) Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • sirolimus Z79.623 — Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
  • steroids
  • inhaled Z79.51 — Long term (current) use of inhaled steroids
  • systemic Z79.52 — Long term (current) use of systemic steroids
  • tacrolimus Z79.621 — Long term (current) use of calcineurin inhibitor
  • tamoxifen (Nolvadex) Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • tofacitinib Z79.622 — Long term (current) use of Janus kinase inhibitor
  • topoisomerase inhibitor Z79.634 — Long term (current) use of topoisomerase inhibitor
  • topotecan Z79.634 — Long term (current) use of topoisomerase inhibitor
  • toremifene (Fareston) Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
  • vinblastine Z79.633 — Long term (current) use of mitotic inhibitor
  • vincristine Z79.633 — Long term (current) use of mitotic inhibitor

Common questions about Long-term drug therapy ICD-10 codes

What is the ICD-10 code for 5-fluorouracil long-term drug therapy?

Z79.631 — Long term (current) use of antimetabolite agent.

What is the ICD-10 code for 6-mercaptopurine long-term drug therapy?

Z79.631 — Long term (current) use of antimetabolite agent.

What is the ICD-10 code for adalimumab long-term drug therapy?

Z79.620 — Long term (current) use of immunosuppressive biologic.

What is the ICD-10 code for alkylating agent long-term drug therapy?

Z79.630 — Long term (current) use of alkylating agent.

What is the ICD-10 code for anastrozole long-term drug therapy?

Z79.811 — Long term (current) use of aromatase inhibitors.

What is the ICD-10 code for antibiotics long-term drug therapy?

Z79.2 — Long term (current) use of antibiotics.

What is the ICD-10 code for anticoagulants long-term drug therapy?

Z79.01 — Long term (current) use of anticoagulants.